Rolf Andrew Ramelmeier's most recent trade in Sangamo Therapeutics Inc was a trade of 1,750 Common Stock done at an average price of $1.3 . Disclosure was reported to the exchange on May 25, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.33 per share. | 25 May 2023 | 1,750 | 171,467 (0%) | 0% | 1.3 | 2,328 | Common Stock |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 210,000 | 210,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 45,000 | 188,835 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.66 per share. | 24 Feb 2023 | 15,618 | 173,217 (0%) | 0% | 2.7 | 41,544 | Common Stock |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 145,800 | 145,800 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 54,000 | 142,429 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.90 per share. | 25 Feb 2022 | 12,388 | 88,429 (0%) | 0% | 5.9 | 73,089 | Common Stock |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 40,000 | 98,199 (0%) | 0% | 0 | Common Stock | |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share. | 25 Feb 2021 | 7,779 | 58,199 (0%) | 0% | 11.2 | 87,047 | Common Stock |
| Sangamo Therapeutics Inc | Rolf Andrew Ramelmeier | EVP, Technical Operations | Sale of securities on an exchange or to another person at price $ 18.13 per share. | 24 Dec 2020 | 3,331 | 68,442 (0%) | 0% | 18.1 | 60,391 | Common Stock |